Meet with JPT @ CRI-CIMT-EATI-AACR conference!

We will be attending the
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
September 6–9, 2017 Mainz/Frankfurt, Germany
Booth # W002

Dr. Holger Wenschuh
Prof. Florian Kern
Dr. Michael Drosch

A fast, flexible and low costs process for neo-epitope based immune monitoring (A220)
A novel, highly standardized, peptide-based ex-vivo stimulation assay for whole blood (A191)

With the success of novel immune therapies, JPT is prepared to partner with you and provide industry- leading peptide tools and services for various immunotherapy strategies, clinical immune monitoring and epitope & target discovery.

Working with investigators in academia and industry, our technical background and track record in the field as well as decades of experience in all peptide chemistry and technology aspects, together will help us work towards a common goal of improved therapies. Have a look at our peptide resources for all immunotherapy development phases.

Please contact us to set-up a face-to-face meeting to discuss your trial or project as I will be present throughout the entire conference!

Stay in touch and be the first to receive the latest news!